[Tumor treatment of metastatic renal cell carcinoma : Comparison of immunotherapy with other drug options]

Urologe A. 2019 Oct;58(10):1208-1211. doi: 10.1007/s00120-019-01038-2.

[Article in German]

Author

A Uhlig^{1

2}

Affiliations

¹ Klinik für Urologie, Universitätsmedizin Göttingen, Göttingen, Deutschland. uroevidence@dgu.de.
² UroEvidence@Deutsche Gesellschaft für Urologie, Nestorstraße 8/9, 10709, Berlin, Deutschland. uroevidence@dgu.de.

PMID: 31471642
DOI: 10.1007/s00120-019-01038-2

No abstract available

Publication types

Comparative Study
Review

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Carcinoma, Renal Cell / drug therapy*
Carcinoma, Renal Cell / pathology
Carcinoma, Renal Cell / therapy*
Humans
Immunotherapy / methods*
Kidney Neoplasms / drug therapy*
Kidney Neoplasms / pathology
Kidney Neoplasms / therapy*
Treatment Outcome